Staar Surgical (STAA) Non-Current Deffered Revenue (2015 - 2026)

Staar Surgical (STAA) posted Non-Current Deffered Revenue of $89000.0 for Q2 2026, little changed on a QoQ basis from $89000.0 in Q1 2026.

Staar Surgical (STAA) Non-Current Deffered Revenue (2015 - 2026) Analysis & Trends

Staar Surgical's Non-Current Deffered Revenue history runs 6 years deep, the most recent figure standing at $89000.0 for Q2 2026.

Quarterly Non-Current Deffered Revenue changed N/A year-over-year to $89000.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $89000.0 (changed N/A YoY) and the FY2026 annual result came in at $89000.0, changed N/A from the prior year.
Non-Current Deffered Revenue was $89000.0 for Q2 2026 at Staar Surgical, roughly flat from $89000.0 in the prior quarter.
Across five years, Non-Current Deffered Revenue topped out at $89000.0 in Q3 2025 and bottomed at $89000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Deffered Revenue (Qtr)
1	Alcon	32,734,969.19 Bn	32,734,967.53 Bn	1.53 Bn	-
2	Intuitive Surgical	117.50 Bn	112.41 Bn	1.96 Bn	-
3	Becton Dickinson	42.93 Bn	42.11 Bn	2.15 Bn	-
4	Medline	30.82 Bn	36.66 Bn	1.84 Bn	-
5	Resmed	27.90 Bn	26.23 Bn	890.98 Mn	163.15 Mn
6	West Pharmaceutical Services	26.76 Bn	26.23 Bn	329.20 Mn	13.90 Mn
7	Cooper Companies	15.30 Bn	15.16 Bn	735.40 Mn	208.80 Mn
8	Solventum	13.46 Bn	12.90 Bn	1.10 Bn	-
9	Align Technology	12.02 Bn	10.96 Bn	736.59 Mn	-
10	Staar Surgical	1.21 Bn	1.04 Bn	68.86 Mn	89,000.00

Download Data